Publications
- view 2010; Ceccherini-Silberstein F, et al; Pyrosequencing & Raltegravir Resistance; CROI
- view 2010; Dunn D, et al; virological residual activity, abacavir/zidovudine/lamivudine; CROI
- view 2010; Pattery T, et al; Comparison Virco NS5B Sequence & Trugene™ HCV 5’NC; 5th International Workshop on HCV-R-NC
- view 2010; Pattery T, et al; Clinical efficiency HCV NS3 Protease N-terminal; AASLD
- view 2010; Pattery T, et al; Rare HIV-1 drug resistance & antagonistic effects; EHDRW
- view 2010; Van Der Borght K, et al; Genetic Diversity & HIV Resistance; EHDRW 2010
- view 2011; Intro to Virco Company & Products
- view 2011; Pattery T, et al; Comparison HCV NS5B Sequence & Prototype BLAST Analysis, DAA target gene; 6th International Workshop on HCV-R-NC
- view 2011; Van Den Zegel P, et al; Proficiency testing panel & HCV NS3 protease replicon-based phenotyping assay; AASLD
